:quality(85)/cloudfront-us-east-1.images.arcpublishing.com/infobae/R5BNJX7RHGU5FSPXQJHMRLXVKE.jpg)
The government said on Wednesday that New Zealand’s drug regulator Metsoff had approved the emergency use of the Covit-19 vaccine, developed by US laboratory Pfizer in collaboration with Germany’s Bioendech. / Photo taken on February 1, 2021 / REUTERS / Mike Blake
Mike Blake
WELLINGTON (Reuters) – New Zealand drug regulator Metsoff on Wednesday approved the emergency use of the Kovit-19 vaccine, developed by US laboratory Pfizer in collaboration with Germany’s Bioendech.
Prime Minister Jacinta Artern said in a statement that this was a “positive step” in the fight against the epidemic. “We can now begin preparations for the first phase of our vaccination campaign.”
Officials said vaccines should be given by the end of the first quarter. Before the entire population is vaccinated in the second half of the year, people considered to be at high risk will receive the first dose.
(Praveen Menon; French version by Jean Tersian)
“Typical beer advocate. Future teen idol. Unapologetic tv practitioner. Music trailblazer.”
More Stories
Canoeing queen Carrington wants to add to New Zealand's record at the Paris Games
FRV Australia and Genesis begin construction of 63 MW solar plant in New Zealand – pv magazine Spain
Beekeeper La Carlotta | From La Carlotta to New Zealand